Notes from Dr. Thomas George's Presentation on Obesity

Dr. Thomas George is a family nurse practitioner specializing in evidence-based patient-centered care of people with obesity.
His doctoral work focuses on translating obesity research into primary care practice.
He serves as the clinic director of Wellspring Weight and Wellness.
Also a pathophysiology professor at Northwestern Nazarene University.
Fellow of the Obesity Medicine Association (OMA).
Completed a certificate of advanced education in obesity medicine and holds a primary care obesity management certificate from the Obesity Society.
Chairs the OMA CME overview committee and is a contributing author of the forthcoming 2026 obesity algorithm.
Active member of the Obesity Society, serving as a presenter at various workshops and conferences.
Certified personal trainer and weight loss specialist with the National Academy of Sports Medicine.
Veteran of the US Army and Navy.
Personal experience with obesity, having maintained over a 100-pound weight loss, providing him with unique insight into the condition.

Title: "Phenotype Driven Treatment Doubles Weight Loss"
Thesis: Matching specific interventions with specific phenotypes can significantly enhance treatment outcomes for obesity.

Background: Formerly a lean infantryman, transitioned to obesity due to a traumatic brain injury and hypothalamic damage, leading to weight gain of 330 pounds.
Experience hyperphagia and compulsive thoughts about food, referred to as "food noise".
Encountered skepticism and misunderstanding regarding his conditions before receiving correct information from a neuroendocrinologist.

Definition: Obesity is described as a chronic, relapsing, multifactorial, and neurobehavioral disease.
Key aspects of the definition: - It is chronic: There is no cure, but it can be treated. - It is relapsing: Without intervention, obesity often returns. - It is multifactorial: Involves various factors including genetics, environment, and behavior. - Involves adipose dysfunction, termed adiposeopathy, which leads to multiple health complications. - Obesity is linked to over 236 other conditions, including 13 specific cancers.

Even a 5% reduction in total body weight can arrest, reverse, or prevent many obesity-related conditions and cancers.

Obesity must be viewed beyond caloric intake vs. expenditure: - Predetermined predispositions can dictate how individuals store energy. - Up to 70% heritability in weight with 1,700 potential genetic contributors identified. - Discussion of monogenic forms of obesity, specifically involving single-gene mutations affecting the melanocortin-4 pathway.

Exploration of neurobehavioral signals, highlighting the psychological struggle individuals face with weight, mood, and appetite regulation.

The discussion intertwines pharmacology with pathophysiology to highlight therapeutic targets for obesity treatment.
Pathway diagrams illustrating obesity's multifactorial components, suggesting obesity is not solely a result of poor diet and exercise.

Introduction of obesity phenotypes and their significance in treatment plans.
Identified phenotypes include: - Hungry Brain Phenotype: Delayed signaling leads to overeating. - Hungry Gut: Rapid gastric emptying results in early post-meal hunger. - Emotional Eater Phenotype: Emotional cues overrule hunger signals, leading to overeating based on mood rather than physical hunger. - Slow Metabolism Phenotype: Identifying individuals with true metabolic slowdowns through calorimetry.

Four pillars of obesity treatment: nutrition, physical activity, behavioral interventions, and medication. - Importance of individualized treatment based on phenotype. - Discusses exercise as a prescription similar to medication. Encouragement of enjoyable physical activity rather than traditional exercise.
Medications: - Use of pharmacological agents like GLP-1 agonists, phentermine, and topiramate, either separately or in combination, depending on the phenotype.

Insights into the role of societal factors, such as the food industry's influence on diet, and the need for awareness regarding stigma and bias associated with obesity in healthcare settings.
Stress response, sleep quality, and their impacts on obesity.

Emphasis on the necessity of a compassionate approach to treatment. - Avoiding the term "morbid obesity" to reduce stigma. - Encouraging continual education on obesity for healthcare providers.
Final slides showcasing obesity medicines currently available.

The presentation emphasized the complexity of obesity and the importance of understanding individual patient narratives.
Highlighted the need for a stigma-free approach in treating patients with obesity, advocating for respectful, patient-centered care.